Low-Dose NSAIDs Efficacy in Orthopedic Applications

Sports Med Arthrosc Rev. 2022 Sep 1;30(3):147-161. doi: 10.1097/JSA.0000000000000353. Epub 2022 Aug 3.

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) [cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors] and COXIBs (the COX-2 selective inhibitors) may induce several potentially severe and life-threatening issues especially in elderly patients. The use of low-dose NSAIDs is associated with lower risk of side effects compared to the standard dosage. Low-dose NSAIDs could minimize the side effects of these drugs while maintaining their clinical efficacy and effectiveness. The present study evaluates the effectiveness and safety of low-dose NSAIDs in musculoskeletal applications.

MeSH terms

  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal* / therapeutic use
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors* / adverse effects
  • Humans

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase 2